Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

NCT03417284 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Plasma Cell Myeloma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Filgrastim-sndz
DRUG: Melphalan Hydrochloride

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]